206 related articles for article (PubMed ID: 33365271)
1. Comparison of Manual and Semi-Automatic [
Spohn SKB; Kramer M; Kiefer S; Bronsert P; Sigle A; Schultze-Seemann W; Jilg CA; Sprave T; Ceci L; Fassbender TF; Nicolay NH; Ruf J; Grosu AL; Zamboglou C
Front Oncol; 2020; 10():600690. PubMed ID: 33365271
[TBL] [Abstract][Full Text] [Related]
2. Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of reference.
Zamboglou C; Fassbender TF; Steffan L; Schiller F; Fechter T; Carles M; Kiefer S; Rischke HC; Reichel K; Schmidt-Hegemann NS; Ilhan H; Chirindel AF; Nicolas G; Henkenberens C; Derlin T; Bronsert P; Mavroidis P; Chen RC; Meyer PT; Ruf J; Grosu AL
Radiother Oncol; 2019 Dec; 141():208-213. PubMed ID: 31431386
[TBL] [Abstract][Full Text] [Related]
3. Comparison of
Zamboglou C; Drendel V; Jilg CA; Rischke HC; Beck TI; Schultze-Seemann W; Krauss T; Mix M; Schiller F; Wetterauer U; Werner M; Langer M; Bock M; Meyer PT; Grosu AL
Theranostics; 2017; 7(1):228-237. PubMed ID: 28042330
[TBL] [Abstract][Full Text] [Related]
4. Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network.
Kostyszyn D; Fechter T; Bartl N; Grosu AL; Gratzke C; Sigle A; Mix M; Ruf J; Fassbender TF; Kiefer S; Bettermann AS; Nicolay NH; Spohn S; Kramer MU; Bronsert P; Guo H; Qiu X; Wang F; Henkenberens C; Werner RA; Baltas D; Meyer PT; Derlin T; Chen M; Zamboglou C
J Nucl Med; 2021 Jun; 62(6):823-828. PubMed ID: 33127624
[TBL] [Abstract][Full Text] [Related]
5. [
Bettermann AS; Zamboglou C; Kiefer S; Jilg CA; Spohn S; Kranz-Rudolph J; Fassbender TF; Bronsert P; Nicolay NH; Gratzke C; Bock M; Ruf J; Benndorf M; Grosu AL
Radiother Oncol; 2019 Dec; 141():214-219. PubMed ID: 31431366
[TBL] [Abstract][Full Text] [Related]
6.
Draulans C; Pos F; Smeenk RJ; Kerkmeijer L; Vogel WV; Nagarajah J; Janssen M; Mai C; Heijmink S; van der Leest M; Zámecnik P; Oyen R; Isebaert S; Maes F; Joniau S; Kunze-Busch M; De Roover R; Defraene G; van der Heide UA; Goffin K; Haustermans K
Pract Radiat Oncol; 2021; 11(3):202-211. PubMed ID: 33941347
[TBL] [Abstract][Full Text] [Related]
7. Optimal
Draulans C; De Roover R; van der Heide UA; Kerkmeijer L; Smeenk RJ; Pos F; Vogel WV; Nagarajah J; Janssen M; Isebaert S; Maes F; Mai C; Oyen R; Joniau S; Kunze-Busch M; Goffin K; Haustermans K
Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1211-1218. PubMed ID: 33025093
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Multiple Segmentation Methods for Volumetric Delineation of Primary Prostate Cancer with Prostate-Specific Membrane Antigen-Targeted
Wang F; Liu C; Vidal I; Mana-Ay M; Voter AF; Solnes LB; Ross AE; Gafita A; Schaeffer EM; Bivalacqua TJ; Pienta KJ; Pomper MG; Lodge MA; Song DY; Oldan JD; Allaf ME; De Marzo AM; Sheikhbahaei S; Gorin MA; Rowe SP
J Nucl Med; 2024 Jan; 65(1):87-93. PubMed ID: 38050147
[TBL] [Abstract][Full Text] [Related]
9. Intraindividual Comparison Between [
Marinescu IM; Spohn SKB; Kiefer S; Bronsert P; Ceci L; Holzschuh J; Sigle A; Jilg CA; Rühle A; Sprave T; Nicolay NH; Winzer R; Rehm J; Kotzerke J; Hölscher T; Grosu AL; Ruf J; Benndorf M; Zamboglou C
Front Oncol; 2022; 12():880042. PubMed ID: 35912219
[TBL] [Abstract][Full Text] [Related]
10. Intraindividual comparison between
Spohn S; Jaegle C; Fassbender TF; Sprave T; Gkika E; Nicolay NH; Bock M; Ruf J; Benndorf M; Gratzke C; Grosu AL; Zamboglou C
Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2796-2803. PubMed ID: 32342192
[TBL] [Abstract][Full Text] [Related]
11. Gross tumor volume delineation in primary prostate cancer on
Zhang YN; Lu ZG; Wang SD; Lu X; Zhu LL; Yang X; Fu LP; Zhao J; Wang HF; Xiang ZL
Cancer Imaging; 2022 Jul; 22(1):36. PubMed ID: 35869521
[TBL] [Abstract][Full Text] [Related]
12. Deep learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancer.
Holzschuh JC; Mix M; Ruf J; Hölscher T; Kotzerke J; Vrachimis A; Doolan P; Ilhan H; Marinescu IM; Spohn SKB; Fechter T; Kuhn D; Bronsert P; Gratzke C; Grosu R; Kamran SC; Heidari P; Ng TSC; Könik A; Grosu AL; Zamboglou C
Radiother Oncol; 2023 Nov; 188():109774. PubMed ID: 37394103
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer GTV delineation with biparametric MRI and
Hearn N; Blazak J; Vivian P; Vignarajah D; Cahill K; Atwell D; Lagopoulos J; Min M
Br J Radiol; 2021 Mar; 94(1119):20201174. PubMed ID: 33507812
[TBL] [Abstract][Full Text] [Related]
14. Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference.
Zamboglou C; Carles M; Fechter T; Kiefer S; Reichel K; Fassbender TF; Bronsert P; Koeber G; Schilling O; Ruf J; Werner M; Jilg CA; Baltas D; Mix M; Grosu AL
Theranostics; 2019; 9(9):2595-2605. PubMed ID: 31131055
[No Abstract] [Full Text] [Related]
15. MRI versus ⁶⁸Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer.
Zamboglou C; Wieser G; Hennies S; Rempel I; Kirste S; Soschynski M; Rischke HC; Fechter T; Jilg CA; Langer M; Meyer PT; Bock M; Grosu AL
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):889-897. PubMed ID: 26592938
[TBL] [Abstract][Full Text] [Related]
16. Isotropic Expansion of the Intraprostatic Gross Tumor Volume of Primary Prostate Cancer Patients Defined in MRI-A Correlation Study With Whole Mount Histopathological Information as Reference.
Kramer M; Spohn SKB; Kiefer S; Ceci L; Sigle A; Oerther B; Schultze-Seemann W; Gratzke C; Bock M; Bamberg F; Grosu AL; Benndorf M; Zamboglou C
Front Oncol; 2020; 10():596756. PubMed ID: 33330088
[TBL] [Abstract][Full Text] [Related]
17. Influence of Urethra Sparing on Tumor Control Probability and Normal Tissue Complication Probability in Focal Dose Escalated Hypofractionated Radiotherapy: A Planning Study Based on Histopathology Reference.
Spohn SKB; Sachpazidis I; Wiehle R; Thomann B; Sigle A; Bronsert P; Ruf J; Benndorf M; Nicolay NH; Sprave T; Grosu AL; Baltas D; Zamboglou C
Front Oncol; 2021; 11():652678. PubMed ID: 34055621
[TBL] [Abstract][Full Text] [Related]
18. Focal dose escalation for prostate cancer using
Zamboglou C; Thomann B; Koubar K; Bronsert P; Krauss T; Rischke HC; Sachpazidis I; Drendel V; Salman N; Reichel K; Jilg CA; Werner M; Meyer PT; Bock M; Baltas D; Grosu AL
Radiat Oncol; 2018 May; 13(1):81. PubMed ID: 29716617
[TBL] [Abstract][Full Text] [Related]
19. Comparison of
Walacides D; Meier A; Knöchelmann AC; Meinecke D; Derlin T; Bengel FM; Ross TL; Wester HJ; Derlin K; Kuczyk MA; von Klot CAJ; Christiansen H; Henkenberens C
Strahlenther Onkol; 2019 May; 195(5):420-429. PubMed ID: 30610354
[TBL] [Abstract][Full Text] [Related]
20. (68)Ga-HBED-CC-PSMA PET/CT Versus Histopathology in Primary Localized Prostate Cancer: A Voxel-Wise Comparison.
Zamboglou C; Schiller F; Fechter T; Wieser G; Jilg CA; Chirindel A; Salman N; Drendel V; Werner M; Mix M; Meyer PT; Grosu AL
Theranostics; 2016; 6(10):1619-28. PubMed ID: 27446496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
